SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Moderna to Consult Health Authorities on Norovirus Vaccine Program

Moderna intends to engage with health authorities to determine the path forward for its mRNA-1403 norovirus vaccine candidate program.

MRNA

Related stories